Commission Implementing Regulation (EU) 2019/336 of 27 February 2019 amending Regulation (EU) No 1141/2010 and Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of 1-methylcyclopropene, famoxadone, mancozeb, methiocarb, methoxyfenozide, pirimicarb, pirimiphos-methyl and thiacloprid (Text with EEA relevance.)
Allegato IIANNEX II
In vigore · versione del 1 gen 1001
In Annex I to Regulation (EU) No 1141/2010, the entry for Famoxadone is replaced by the following:
Column A Column B Column C Column D ‘Famoxadone 2012 FI 31 August 2012’